Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- KRYS +6%, NSSC +3.8%, BRK.B +0.5%
Other news:
- CABA +18% (prices 51,725,000 share common stock offering at $2.90 per share)
- CELC +13% (Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort)
- MDV +10.6% (Modiv to be acquired by Global Net Lease (GNL) in an all-stock transaction valued at an enterprise value of approximately $535 million)
- EBAY +9.5% (GameStop (GME) proposes $125 per share bid for eBay in cash and stock deal)
- VNDA +6.9% (U.S. commercial availability of NEREUS)
- MIRM +5.7% (to host investor call to share topline results from the VISTAS study of Volixibat in patients with primary sclerosing cholangitis on May 4)
- EXOD +5.6% (acquires Baanx US for $30 mln to expand crypto payments)
- BTGO +4% (named custodian for Virtune ETP, expanding European crypto footprint)
- INDV +3.5% (announces $175 million accelerated share repurchase)
- WTM +3.2% (unit acquires Hawkeye Electric)
- IREN +2.9% (announces successful energization of its 1.4GW Sweetwater 1 data center site in Texas)
- EVO +2.9% (announced the nomination of a small molecule preclinical development candidate)
- ADMA +2.2% (FDA approval to expand the label for ASCENIV to include pediatric immune compromised patients two years of age and older)
- TTAM +1.8% (completes the acquisition of Keystone Cement Holdings, Inc. and Keystone Cement Company, a Pennsylvania-based cement manufacturer and aggregates producer)
- FTAI +1.7% (files mixed securities shelf offering)
- ELDN +1.6% (files for $500 mln mixed securities shelf offering)
- BMRN +1.3% (presents new data on the effect of long-term treatment with VOXZOGO (vosoritide) on Arm Span, Bone Health and Growth in children with achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting)
- HUT +1.3% (entered into a $200 million, 364-day Bitcoin-backed credit facility with FalconX)